Docusate Sodium Capsule, Liquid Filled
Product Images NDC 55154-4341

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Docusate Sodium (NDC 55154-4341). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

37f7d416 E95f 4234 B51c 8dd03f0e52a0 00

37f7d416 E95f 4234 B51c 8dd03f0e52a0 00
This is a product information for a stool softener called Docusate Sodium, USP 250 mg. It comes in a pack of 10 softgels and each softgel contains 13 mg of Sodium. The product is designed to relieve occasional constipation and prevent dry, hard stools. It generally produces a bowel movement within 12 to 72 hours. The product is not intended for children under 12 years of age unless instructed by a doctor. The pack has a warning label indicating that the unit dose package is not child resistant and is intended for institutional use only. The product contains several inactive ingredients, including FDAC Red #40, FDAC Yellow #6, Gelati, Glycerin, and Sorbitol. The product is manufactured in the USA and distributed by Cardinal Health. The label provides further directions for use and storage, as well as warnings about overdose, rectal bleeding, and failure to have a bowel movement after use. Overall, the product seems to be designed to offer relief from occasional constipation.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.